MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.030
-0.050 (-4.63%)
At close: Oct 9, 2025, 4:00 PM EDT
1.030
0.00 (0.00%)
After-hours: Oct 9, 2025, 4:00 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $24.68 million as of October 9, 2025. Its market cap has decreased by -8.59% in one year.
Market Cap
24.68M
Enterprise Value
8.64M
1-Year Change
-8.59%
Ranking
Category
Stock Price
$1.03
Market Cap Chart
Since August 5, 2016, MetaVia's market cap has decreased from $84.50M to $24.68M, a decrease of -70.79%. That is a compound annual growth rate of -12.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 26.10M | 49.14% |
| Dec 31, 2024 | 17.50M | -2.23% |
| Dec 29, 2023 | 17.90M | 280.85% |
| Dec 30, 2022 | 4.70M | -85.49% |
| Dec 31, 2021 | 32.40M | -62.41% |
| Dec 31, 2020 | 86.20M | 1,557.69% |
| Dec 31, 2019 | 5.20M | -55.17% |
| Dec 31, 2018 | 11.60M | -86.27% |
| Dec 29, 2017 | 84.50M | 16.23% |
| Dec 30, 2016 | 72.70M | -13.96% |
| Aug 5, 2016 | 84.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |